Copyright Reports & Markets. All rights reserved.

Global AAV Vector-Based Gene Therapy Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of AAV Vector-Based Gene Therapy Drugs by Type
    • 1.3.1 Overview: Global AAV Vector-Based Gene Therapy Drugs Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global AAV Vector-Based Gene Therapy Drugs Consumption Value Market Share by Type in 2023
    • 1.3.3 AAV2 Vector
    • 1.3.4 AAV5 Vector
    • 1.3.5 Others
  • 1.4 Global AAV Vector-Based Gene Therapy Drugs Market by Application
    • 1.4.1 Overview: Global AAV Vector-Based Gene Therapy Drugs Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospital
    • 1.4.3 Diagnostic and Testing Laboratories
    • 1.4.4 Academic and Research Organizations
    • 1.4.5 Others
  • 1.5 Global AAV Vector-Based Gene Therapy Drugs Market Size & Forecast
  • 1.6 Global AAV Vector-Based Gene Therapy Drugs Market Size and Forecast by Region
    • 1.6.1 Global AAV Vector-Based Gene Therapy Drugs Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global AAV Vector-Based Gene Therapy Drugs Market Size by Region, (2019-2030)
    • 1.6.3 North America AAV Vector-Based Gene Therapy Drugs Market Size and Prospect (2019-2030)
    • 1.6.4 Europe AAV Vector-Based Gene Therapy Drugs Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific AAV Vector-Based Gene Therapy Drugs Market Size and Prospect (2019-2030)
    • 1.6.6 South America AAV Vector-Based Gene Therapy Drugs Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East & Africa AAV Vector-Based Gene Therapy Drugs Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 uniQure
    • 2.1.1 uniQure Details
    • 2.1.2 uniQure Major Business
    • 2.1.3 uniQure AAV Vector-Based Gene Therapy Drugs Product and Solutions
    • 2.1.4 uniQure AAV Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 uniQure Recent Developments and Future Plans
  • 2.2 Spark Therapeutics
    • 2.2.1 Spark Therapeutics Details
    • 2.2.2 Spark Therapeutics Major Business
    • 2.2.3 Spark Therapeutics AAV Vector-Based Gene Therapy Drugs Product and Solutions
    • 2.2.4 Spark Therapeutics AAV Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Spark Therapeutics Recent Developments and Future Plans
  • 2.3 AveXis (Novartis)
    • 2.3.1 AveXis (Novartis) Details
    • 2.3.2 AveXis (Novartis) Major Business
    • 2.3.3 AveXis (Novartis) AAV Vector-Based Gene Therapy Drugs Product and Solutions
    • 2.3.4 AveXis (Novartis) AAV Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 AveXis (Novartis) Recent Developments and Future Plans
  • 2.4 PTC Therapeutics
    • 2.4.1 PTC Therapeutics Details
    • 2.4.2 PTC Therapeutics Major Business
    • 2.4.3 PTC Therapeutics AAV Vector-Based Gene Therapy Drugs Product and Solutions
    • 2.4.4 PTC Therapeutics AAV Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 PTC Therapeutics Recent Developments and Future Plans
  • 2.5 BioMarin
    • 2.5.1 BioMarin Details
    • 2.5.2 BioMarin Major Business
    • 2.5.3 BioMarin AAV Vector-Based Gene Therapy Drugs Product and Solutions
    • 2.5.4 BioMarin AAV Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 BioMarin Recent Developments and Future Plans
  • 2.6 Sarepta Therapeutics
    • 2.6.1 Sarepta Therapeutics Details
    • 2.6.2 Sarepta Therapeutics Major Business
    • 2.6.3 Sarepta Therapeutics AAV Vector-Based Gene Therapy Drugs Product and Solutions
    • 2.6.4 Sarepta Therapeutics AAV Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Sarepta Therapeutics Recent Developments and Future Plans
  • 2.7 Roche
    • 2.7.1 Roche Details
    • 2.7.2 Roche Major Business
    • 2.7.3 Roche AAV Vector-Based Gene Therapy Drugs Product and Solutions
    • 2.7.4 Roche AAV Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Roche Recent Developments and Future Plans
  • 2.8 Pfizer
    • 2.8.1 Pfizer Details
    • 2.8.2 Pfizer Major Business
    • 2.8.3 Pfizer AAV Vector-Based Gene Therapy Drugs Product and Solutions
    • 2.8.4 Pfizer AAV Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Pfizer Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global AAV Vector-Based Gene Therapy Drugs Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of AAV Vector-Based Gene Therapy Drugs by Company Revenue
    • 3.2.2 Top 3 AAV Vector-Based Gene Therapy Drugs Players Market Share in 2023
    • 3.2.3 Top 6 AAV Vector-Based Gene Therapy Drugs Players Market Share in 2023
  • 3.3 AAV Vector-Based Gene Therapy Drugs Market: Overall Company Footprint Analysis
    • 3.3.1 AAV Vector-Based Gene Therapy Drugs Market: Region Footprint
    • 3.3.2 AAV Vector-Based Gene Therapy Drugs Market: Company Product Type Footprint
    • 3.3.3 AAV Vector-Based Gene Therapy Drugs Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global AAV Vector-Based Gene Therapy Drugs Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global AAV Vector-Based Gene Therapy Drugs Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global AAV Vector-Based Gene Therapy Drugs Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global AAV Vector-Based Gene Therapy Drugs Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America AAV Vector-Based Gene Therapy Drugs Consumption Value by Type (2019-2030)
  • 6.2 North America AAV Vector-Based Gene Therapy Drugs Market Size by Application (2019-2030)
  • 6.3 North America AAV Vector-Based Gene Therapy Drugs Market Size by Country
    • 6.3.1 North America AAV Vector-Based Gene Therapy Drugs Consumption Value by Country (2019-2030)
    • 6.3.2 United States AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
    • 6.3.3 Canada AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe AAV Vector-Based Gene Therapy Drugs Consumption Value by Type (2019-2030)
  • 7.2 Europe AAV Vector-Based Gene Therapy Drugs Consumption Value by Application (2019-2030)
  • 7.3 Europe AAV Vector-Based Gene Therapy Drugs Market Size by Country
    • 7.3.1 Europe AAV Vector-Based Gene Therapy Drugs Consumption Value by Country (2019-2030)
    • 7.3.2 Germany AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
    • 7.3.3 France AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
    • 7.3.5 Russia AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
    • 7.3.6 Italy AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific AAV Vector-Based Gene Therapy Drugs Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific AAV Vector-Based Gene Therapy Drugs Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific AAV Vector-Based Gene Therapy Drugs Market Size by Region
    • 8.3.1 Asia-Pacific AAV Vector-Based Gene Therapy Drugs Consumption Value by Region (2019-2030)
    • 8.3.2 China AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
    • 8.3.3 Japan AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
    • 8.3.5 India AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
    • 8.3.7 Australia AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America AAV Vector-Based Gene Therapy Drugs Consumption Value by Type (2019-2030)
  • 9.2 South America AAV Vector-Based Gene Therapy Drugs Consumption Value by Application (2019-2030)
  • 9.3 South America AAV Vector-Based Gene Therapy Drugs Market Size by Country
    • 9.3.1 South America AAV Vector-Based Gene Therapy Drugs Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa AAV Vector-Based Gene Therapy Drugs Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa AAV Vector-Based Gene Therapy Drugs Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa AAV Vector-Based Gene Therapy Drugs Market Size by Country
    • 10.3.1 Middle East & Africa AAV Vector-Based Gene Therapy Drugs Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
    • 10.3.4 UAE AAV Vector-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 AAV Vector-Based Gene Therapy Drugs Market Drivers
  • 11.2 AAV Vector-Based Gene Therapy Drugs Market Restraints
  • 11.3 AAV Vector-Based Gene Therapy Drugs Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 AAV Vector-Based Gene Therapy Drugs Industry Chain
  • 12.2 AAV Vector-Based Gene Therapy Drugs Upstream Analysis
  • 12.3 AAV Vector-Based Gene Therapy Drugs Midstream Analysis
  • 12.4 AAV Vector-Based Gene Therapy Drugs Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    AAV vector-based gene therapy drugs are a class of therapeutic agents used in the treatment of genetic disorders and certain diseases These drugs utilize AAV vectors, which are small, non-enveloped viruses that have a low pathogenic profile and are capable of delivering genetic material into host cells. The genetic material, which be a functional gene or a therapeutic gene, is inserted into the AAV vector and then introduced into the patient's cells, where it is intended to correct genetic mutations or produce therapeutic proteins. AAV vector-based gene therapy has shown promising results in clinical trials for conditions such as Leber congenital amaurosis, spinal muscular atrophy, and certain retinal diseases.
    According to our (Global Info Research) latest study, the global AAV Vector-Based Gene Therapy Drugs market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global AAV Vector-Based Gene Therapy Drugs market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
    Key Features:
    Global AAV Vector-Based Gene Therapy Drugs market size and forecasts, in consumption value ($ Million), 2019-2030
    Global AAV Vector-Based Gene Therapy Drugs market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
    Global AAV Vector-Based Gene Therapy Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
    Global AAV Vector-Based Gene Therapy Drugs market shares of main players, in revenue ($ Million), 2019-2024
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for AAV Vector-Based Gene Therapy Drugs
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global AAV Vector-Based Gene Therapy Drugs market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include uniQure, Spark Therapeutics, AveXis (Novartis), PTC Therapeutics, BioMarin, Sarepta Therapeutics, Roche, Pfizer, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    AAV Vector-Based Gene Therapy Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segmentation
    AAV Vector-Based Gene Therapy Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    AAV2 Vector
    AAV5 Vector
    Others
    Market segment by Application
    Hospital
    Diagnostic and Testing Laboratories
    Academic and Research Organizations
    Others
    Market segment by players, this report covers
    uniQure
    Spark Therapeutics
    AveXis (Novartis)
    PTC Therapeutics
    BioMarin
    Sarepta Therapeutics
    Roche
    Pfizer
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe AAV Vector-Based Gene Therapy Drugs product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of AAV Vector-Based Gene Therapy Drugs, with revenue, gross margin, and global market share of AAV Vector-Based Gene Therapy Drugs from 2019 to 2024.
    Chapter 3, the AAV Vector-Based Gene Therapy Drugs competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and AAV Vector-Based Gene Therapy Drugs market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of AAV Vector-Based Gene Therapy Drugs.
    Chapter 13, to describe AAV Vector-Based Gene Therapy Drugs research findings and conclusion.

    Buy now